DrugsControl Media Services
DrugsControl.org

News Detail

Glenmark Pharma Recalls 15 Lakh Bottles of ADHD Medication in US: FDA (02-03-2025)

Mumbai, 2 March 2025: Glenmark Pharmaceuticals Ltd. is recalling close to 15 lakh bottles of a generic medication used in the treatment of attention deficit hyperactivity disorder in the US market, according to the Food and Drug Administration.

Glenmark Pharmaceuticals......
View Details

Source : PTI
Glenmark Pharmaceuticals Ltd deficit hyperactivity disorder Food and Drug Administration Atomoxetine Capsules

Related News